Study on causes and progression of systemic sclerosis
Part of Skin clinical trials.
This study looks at how systemic sclerosis (a condition causing skin thickening and organ issues) starts and gets worse. It may help researchers find better ways to treat or manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of limited or diffuse systemic sclerosis (also called scleroderma).
- You are between 18 and 80 years old.
- You have regular check-ups at the CUSL hospital.
- You do not have any other autoimmune or inflammatory disease.
- You are not pregnant.
- You are able to read, understand, and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study is looking at people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect internal organs) to learn more about the disease. You may join if you have been diagnosed with this condition and meet a few other requirements.
This research study uses special lab-grown stem cells to understand how systemic sclerosis (a disease that hardens skin and organs) develops and progresses. By studying cells from patients with different types of systemic sclerosis and healthy relatives, researchers hope to find new ways to treat or prevent the disease.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study tests whether blocking a protein called TL1A can help reduce skin thickening and improve the immune system in people with systemic sclerosis (a condition where skin becomes hard and thick). Researchers will compare skin and blood samples from people with systemic sclerosis to healthy volunteers.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
Hear when a new Scleroderma (Limited and Diffuse) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.